RSSSupplements

Defining a Clinically Meaningful Effect  for the Design and Interpretation of Randomized Controlled Trials

Defining a Clinically Meaningful Effect for the Design and Interpretation of Randomized Controlled Trials

| June 1, 2013 | 0 Comments

by Richard S. E. Keefe, PhD; Helena C. Kraemer, PhD; Robert S. Epstein, MD, MS; Ellen Frank, PhD; Ginger Haynes, PhD; Thomas P. Laughren, MD; James McNulty, AbScB; Shelby D. Reed, PhD; Juan Sanchez, MD; and Andrew C. Leon, PhD Dr. Keefe is Professor of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina; Dr. […]

Continue Reading

How Can Registries Contribute to the Development and Evaluation of CNS Therapeutics?

How Can Registries Contribute to the Development and Evaluation of CNS Therapeutics?

| June 1, 2013 | 0 Comments

by Joanne B. Severe, MS, and Annette Stemhagen, DrPH, FISPE Ms. Severe is a research consultant in Rockville, Maryland, and Dr. Stemhagen is with United Biosource Corp. in Bethesda, Maryland. Innov Clin Neurosci. 2013;10(5–6 Suppl A):29S–31S

Continue Reading